Notice of Intent to Sole Source.docx
DOCX document 39 KB Posted
- Solicitation number
- FDA-133991
About this file
This is a Notice of Intent to Award a Sole Source Contract. The Food and Drug Administration (FDA) intends to award a firm-fixed price commercial Purchase Order to Biolog Inc., located at 21124 Cabot Blvd., Hayward, CA 94545, for the purchase of an Integrated Dual-Mode Microbial Phenotypic Analysis System. The acquisition is being conducted under FAR Part 6.302-1 (Only One Responsible Source) and FAR Part 12 (commercial products and services) using simplified acquisition procedures. The NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).
Biolog has been identified as the sole source because it is the only manufacturer capable of providing an integrated platform that simultaneously measures redox respiration and optical density growth kinetics while maintaining compatibility with the FDA's proprietary phenotypic microarray plates and existing validated workflows. Market research confirmed that no alternative analyzers meet these integrated capability requirements. Other firms wishing to be considered must submit a detailed capability statement to Janice Heard at janice.heard@fda.hhs.gov by July 9, 2026, demonstrating their ability to meet the stated requirements. The Government retains sole discretion to determine whether competing responses warrant changing the sole source award decision.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Notice of Intent to Award a Sole Source Contract
Notice of Intent to Award a Sole Source Contract to Biolog (FDA-133991) The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price commercial Purchase Order (PO) to Biolog Inc. 21124 Cabot Blvd., Hayward, CA 94545 for the Purchase of Integrated Dual-Mode Microbial Phenotypic Analysis System in accordance with the authority under FAR RFO Part 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The NAICS Code for this action is 334516–Analytical Laboratory Instrument Manufacturing industry. This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.
Biolog is the only manufacturer of the Integrated Dual-Mode Microbial Phenotypic Analysis System that is uniquely capable of integrating with the FDA's existing maintaining compatibility with phenotypic microarray plates and validated workflows. Market research did not identify any alternative analyzers capable of providing an integrated platform that simultaneously measures redox respiration and optical density growth kinetics, compatibility with proprietary phenotypic microarray plates currently in use.
This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement to Janice Heard at janice.heard@fda.hhs.gov no later than July 09, 2026. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
image1.jpeg
File details come from the government source that posted it. Updated .